Delivery Order SPE2DR25D1053-SPE2DR26FT831
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Synthroid 50 MCG tablets (1,000-unit quantity) valued at $1,355.36. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 16, 2025. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Synthroid 150 micrograms tablets in quantities of 1,000 units. This competitive award, valued at $1,308.24, represents a firm fixed price delivery order with an ultimate completion date of October 29, 2025. The contract is performed at the contractor's facility in Conshohocken, Pennsylvania, and carries no set-aside designation. This award is issued as a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of 1,000 tablets of Synthroid 25 micrograms, with a ceiling value of $1,539.70. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a $6,174.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of 1,000 tablets of Synthroid 50 micrograms. This competitive award, which carries an ultimate completion date of September 17, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.98 to AmerisourceBergen Drug Corp for the supply of Synthroid 25 microgram tablets (90-count units) on August 26, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 16, 2025, for 1,000 tablets of Synthroid 75 micrograms. This competitively awarded, non-set-aside contract has a ceiling value of $1,482.33 and is priced on a firm fixed-price basis, with an ultimate completion date of October 17, 2025. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units, with a ceiling value of $1,678.76. This non-competitive, firm fixed price delivery order is set to be completed by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,808.16 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 micrograms on October 22, 2025, with completion scheduled for October 23, 2025. This competitive, non-set-aside award uses firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order will be fulfilled from the vendor's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $50,535.07 delivery order on July 18, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the agency. Performance will be completed by July 21, 2025, with fulfillment occurring at the company's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT831Delivery Order
This delivery order, valued at $6,272.87, was awarded by the Defense Logistics Agency (DLA) on November 12, 2025, to AmerisourceBergen Drug Corp for the supply of Synthroid 25 MCG tablets in quantities of 1,000 units. The contract utilizes firm fixed pricing and is not subject to any set-aside designation, indicating it was competitively awarded. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 13, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare operations globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal vendor for the Defense Logistics Agency's medical supply chain. The company maintains an extensive portfolio of federal contract awards covering a broad spectrum of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a mature federal contractor with significant existing relationships with the Defense Health Agency and other government healthcare systems, AmerisourceBergen demonstrates ongoing capability to fulfill federal medical procurement requirements through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 11/12/25 |